A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.

Zepbound’s manufacturer provides detailed information that can help people navigate this process. If a person is on government or federal aid, such as Medicare or Medicaid, it may be harder to ...

(CNN) — Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the ...

Zepbound is a dual GIP and GLP-1 receptor agonist, FDA-approved for the treatment of obesity, as well as for adults with moderate-to-severe obstructive sleep apnea and obesity. The latest price ...

Additionally, Zepbound is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnoea and obesity. Zepbound should be used with a reduced-calorie diet and increased physical activity ...

Zepbound may not be as widely known as its competitors, but the weight-loss drug may soon be more accessible than the rest. Eli Lilly, the manufacturer of Zepbound, which is FDA-approved to help treat ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...